The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease (Q30886687)

27 June 2017

1 reference

title

The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease (English)

1 reference

positron emission tomography

27 June 2017

0 references

1 reference

W-D Heiss

1 reference

27 June 2017

R Hilker

1 reference

27 June 2017

publication date

1 January 2004

1 reference

European Journal of Neurology

27 June 2017

published in

1 reference

27 June 2017

1 reference

27 June 2017

1 reference

27 June 2017

page(s)

5-12

1 reference

T2 relaxation time in patients with Parkinson's disease

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Parkinson's disease in twins studied with 18F-dopa and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Functional effects of striatal dysfunction in Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Positron emission tomography demonstrates frontal cortex and basal ganglia hypometabolism in dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

T2*-weighted MRI differentiates multiple system atrophy from Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Aetiology of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

The metabolic topography of parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

Differentiation of atypical parkinsonian syndromes with routine MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1351-5101.2003.00709.X

10.1046/J.1351-5101.2003.00709.X

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference